Bioactive nutrition: Human milk and milk-derived oligosaccharides
- HMO* and MOS promote a gut microbiome closer to breastfed infants including an increase in bifidobacteria.
- HMO* and MOS decrease the abundance of potentially and opportunistic pathogenic bacteria in the microbiome, respectively.
- HMO* significantly reduced illness (LRTI and bronchitis) and antibiotic use through 12 months of age.
- MOS enhances intestinal immunity and GI barrier integrity/permeability.
4 min read